New Zealand is very healthy. Is liquid calcium true or false?

On 1984, China passed the Drug Administration Law of People's Republic of China (PRC). At present, the main problems are that laws are not obeyed, local protectionism and supervision are too weak, and further efforts are needed to gradually reverse and overcome them. I. Production field At present, most drugs produced by large and medium-sized pharmaceutical companies are qualified. Unqualified drugs mainly come from small pharmaceutical factories, and fake and inferior drugs mostly come from illegal underground factories. 1993 The "00 1 counterfeit drug case" that caused a sensation in the whole country involved Zhoukou No.1 Veterinary Drug Factory in Henan Province. Since 1986, no raw powder production ingredients have been added, and even veterinary drugs have been sold as human drugs, producing and selling fake and inferior veterinary drugs and human drugs in 6 batches with a value of 2.5 million yuan. The case ranks first in the investigation of counterfeit drugs in China because of its long time of manufacturing and selling counterfeit drugs, large production scale, wide sales area, hidden means and thick protective net. Second, in the circulation field, at present, many units are involved in drug business, resulting in confusion in business. According to a survey in a province, there are 2757 pharmaceutical wholesale enterprises in the province, including 2257 collective and self-employed enterprises, accounting for 82%. The internal procurement staff of distribution enterprises do not talk about professional ethics, ignore political rules and regulations, accept "kickbacks" and lead wolves into the room. "Rebate" has become an important reason for the proliferation of counterfeit and inferior drugs. In the field of circulation, it is difficult for doctors and patients to distinguish between true and false by infringing on the image of famous brands. 1992, after seven children in Shandong, Sichuan, Hubei and Hunan were killed by injecting fake injections produced by Shanghai Haipu Pharmaceutical Factory, the reputation and economy of the factory suffered huge losses, and the sales in that year decreased by more than one million. In recent years, it has become a common phenomenon that patients' prescriptions exceed patients' public consumption. Some unscrupulous traders collect or buy drugs accumulated in the hands of urban residents at low prices, and a large number of them have been explicitly eliminated and expired. By changing the packaging, forging manufacturers and other means, they use these fake and inferior drugs as bait, sell them at prices lower than those stipulated by the state, and give buyers kickbacks, benefits and handling fees, which has become another important factor for fake and inferior drugs to enter the circulation field. 3. Import Channels The lax management of drug import channels is one of the important factors for the proliferation of counterfeit and inferior drugs at present. At present, the global proliferation of counterfeit drugs has become a thorny social problem for governments all over the world. The killers of counterfeit drugs have been from Southeast Asia, Argentina, Greece and Italy to Britain and the United States. Italy can be called the headquarters of counterfeit drugs in the world. The World Health Organization and pharmaceutical companies in various countries actively adopt various anti-counterfeiting technologies and measures. The proliferation of counterfeit and inferior drugs in the world directly threatens the safety of drug use in China's pharmaceutical market and medical units. In recent years, a batch of cephalosporin vi powder for injection imported from Spain was found, and the color of the solution was unqualified, and the import inspection report was forged. A batch of capsules imported from Japan are fake and shoddy, and they are fraudulent designs, trademarks and brand names. In order to strengthen the management of imported drugs and protect patients' health and life safety, the Ministry of Health of China promulgated the Measures for the Administration of Imported Drugs in the form of Ministry of Health Order in June 20051990165438+1October. In the management of imported drugs, the general requirement of the state is that it can be imported, but it needs strict management. The Measures for the Administration of Imported Drugs ensures the smooth operation of economic activities such as management, import and export, and at the same time makes clear provisions on the inspection and sales of imported drugs. Good luck!